Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569153 · ClinicalTrials.gov registry record · Phase 1
Safety Study of TAK-700 in Subjects With Prostate Cancer.
A Phase 1 study, sponsored by Millennium Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 123
- Enrollment target
NCT00569153 is a Phase 1 study that has completed, run by Millennium Pharmaceuticals. The registered enrollment target is 123 participants.
The verdict
NCT00569153, a Phase 1 study, has completed, sponsored by Millennium Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 123 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and tolerability of TAK-700 in patients with asymptomatic metastatic, androgen independent prostate cancer.
Interventions
- DRUG TAK-700
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2008-04 |
| Est. Completion | 2013-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00569153
The ClinicalTrials.gov registry entry for NCT00569153 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Millennium Pharmaceuticals, which has 135 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TAK-700 is the first listed.
NCT00569153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00569153 about?
NCT00569153 is a clinical study titled "Safety Study of TAK-700 in Subjects With Prostate Cancer.". The purpose of this study is to determine the safety and tolerability of TAK-700 in patients with asymptomatic metastatic, androgen independent prostate cancer.
What is the current status of trial NCT00569153?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 123 participants. The study started on 2008-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00569153?
The interventions under investigation include: TAK-700 (DRUG).
Who is sponsoring clinical trial NCT00569153?
This trial is sponsored by Millennium Pharmaceuticals, which has 135 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.